Content
All Posts > Content under Global Markets
College Savings Vs. Retirement Savings
Article By:
Bankers Anonymous
Read
Monday, March 3, 2014 7:11 AM EDT
An astute reader pointed out some qualifications to my Friday post on 529 college savings accounts – specifically, reasons not to fund them.
Investing In Investment Brokerage Earnings Growth
Article By:
Michael Michaud
Read
Monday, March 3, 2014 7:04 AM EDT
After a small hiccup, markets are again back on track with the S&P 500 now posting a modest gain for the first two months of the year
In this article: AMTD
March Is Historically A Bullish Month – Weekly Market Outlook
Article By:
Price Headley
Read
Monday, March 3, 2014 6:58 AM EDT
It may have been modest, but the modest move made by the market last week pushed stocks above a very significant hurdle, which has big implications from here. In other words, don't let the small size of last week's gain fool you – it was a big deal, and may have (read 'probably did') reignited the rally that's been in place since late-2011.
Chinese Manufacturing PMI Slumps To 8-Month Low, Services PMI To 3-Month High; Goldman Admits Growth Decelerating
Article By:
Tyler Durden
Read
Monday, March 3, 2014 6:48 AM EDT
Chinese manufacturing PMI fell to an 8-month low holding barely above the crucial 50 level yesterday forcing Goldman to admit that "this signals further deceleration" in Chinese growth.
Uncertainty In Gold’s Next Directional Move
Article By:
Jeff Pierce
Read
Monday, March 3, 2014 6:40 AM EDT
Gold reversed this morning after making fresh Daily Cycle highs before moving over $20 to the session lows. Most of the move can be attributed to the dollar's fairly powerful rally as it confirmed a new DailyCycle of its own.
In this article: GLD
Two Myths About The Ukrainian Conflict
Article By:
Sober Look
Read
Monday, March 3, 2014 6:37 AM EDT
Myth # 1: Those who believe that Putin's actions with respect to Ukraine could hurt Russia economically should think again.
Natural Gas, UNG Weekly Chart
Article By:
Gary Tanashian
Read
Monday, March 3, 2014 6:33 AM EDT
A weekly chart for an NFTRH subscriber and anyone else who is interested.
In this article: UNG
Daily Market Commentary: Breakout In S&P And Russell 2000
Article By:
Declan Fallon
Read
Monday, March 3, 2014 6:28 AM EDT
The real breakouts occurred in the S&P and Russell 2000 on Thursday, although it was bit anti-climatic to see these indices make the push given the Nasdaq and Nasdaq 100 had broken out in the weeks before.
In this article: SPX
Year-To-Date Commodity Winners
Article By:
Acting Man
Read
Monday, March 3, 2014 6:07 AM EDT
The top performing commodity so far this year has been coffee, which erased almost to years of declines within a few weeks in a rally driven by news of a worsening drought in Brazil.
In this article: GLD
China: Official PMI Slows To Near Neutral
Article By:
John Lounsbury
Read
Monday, March 3, 2014 5:54 AM EDT
Econintersect: The official government PMI (Purchasing Managers' Index) for manufacturing came in lower than expected for February.
Near-Bankrupt Rome Bailed Out As Italy Unemployment Rises To All Time High, Grows By Most On Record In 2013
Article By:
Tyler Durden
Read
Monday, March 3, 2014 5:50 AM EDT
A few days ago, we reported that, seemingly out of the blue, the city of Rome was on the verge of a "Detroit-style bankruptcy."
Look At This Stock - YOD
Article By:
Jeff Pierce
Read
Monday, March 3, 2014 5:42 AM EDT
Small float (11million) and on the day of it's breakout it traded 12 million shares and the next day 20 million, so it basically traded it's entire float 3 times over. That means lots of new shareholders that are in profit with a bullish chart pattern forming, and this could be one to watch if you are looking for a speculative stock to put some money in.
In this article: NFLX
The Gray State Fait Accompli
Article By:
Russ Winter
Read
Monday, March 3, 2014 12:14 AM EDT
“When the people fear their government there is tyranny.”
Concerns About The Super Potent New Opiate Painkiller Zohydro
Article By:
Ilene Carrie
Read
Sunday, March 2, 2014 11:00 PM EDT
Zohydro, a new, super potent opiate pain killer, received FDA approval on Oct. 25, 2014, in spite of significant concerns regarding its potential for abuse.
In this article: ZGNX
